Literature DB >> 25871852

Remote chemotherapy supervision model for rural cancer care: perspectives of health professionals.

D Jhaveri1, S Larkins1,2, J Kelly1,3,4, S Sabesan1,3,5.   

Abstract

Townsville Cancer Centre (TCC), a tertiary cancer centre in North Queensland, Australia, provides chemotherapy services to surrounding small rural towns using the Queensland Remote Chemotherapy Supervision model (QReCS). Under this model, selected chemotherapy regimens are administered in rural hospitals by rural based generalist doctors and nurses, under the supervision of TCC-based medical oncologists and chemotherapy competent nurses through videoconferencing. We sought to explore the perspectives of health professionals participating in QReCS. This qualitative study used semi-structured interviews with 19 participants, including nine nurses, eight doctors, one rural pharmacist and one administration officer. The interviews were recorded and transcribed. Transcripts were examined using iterative thematic analysis. Four major themes were identified from the data: (1) benefits of the model, (2) enablers of implementation, (3) operational requirements for optimal functioning and (4) disadvantages of the model. The reported benefits of the model were patient convenience, inter-professional communication across health district borders, expanded scope of practice, continuity of care and maintenance of patient safety and compliance with guidelines while delivering chemotherapy. Further improvements in the quality of training for rural nurses, coordination between urban and rural sites and between health professionals and documentation of clinical encounters would optimise the operation of the model. QReCS appears to provide many benefits to patients and health professionals and a framework for safe administration of chemotherapy in rural areas. Coordination of care, the quality of training for rural nurses as well as clinical documentation needs to improve to optimise the operation of the model.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  chemotherapy; oncology; remote; rural; telemedicine

Mesh:

Substances:

Year:  2015        PMID: 25871852     DOI: 10.1111/ecc.12309

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN: 0961-5423            Impact factor:   2.520


  8 in total

1.  Demographic, clinical, and geographical factors associated with lack of receipt of physician recommended chemotherapy in women with breast cancer in Texas.

Authors:  Parijatham S Thomas; Caleb A Class; Tanmay R Gandhi; Arvind Bambhroliya; Kim-Anh Do; Abenaa M Brewster
Journal:  Cancer Causes Control       Date:  2019-03-13       Impact factor: 2.506

Review 2.  The role of digital health technology in rural cancer care delivery: A systematic review.

Authors:  Bonny B Morris; Brianna Rossi; Bernard Fuemmeler
Journal:  J Rural Health       Date:  2021-09-04       Impact factor: 5.667

3.  Effectiveness of Telenursing for Postoperative Complications in Patients with Prostate Cancer.

Authors:  Daisuke Sato
Journal:  Asia Pac J Oncol Nurs       Date:  2020-09-14

4.  Cancer care in regional Australia from the health professional's perspective.

Authors:  Fiona Crawford-Williams; Belinda Goodwin; Sonja March; Michael J Ireland; Melissa K Hyde; Suzanne K Chambers; Joanne F Aitken; Jeff Dunn
Journal:  Support Care Cancer       Date:  2018-04-25       Impact factor: 3.603

5.  Mobile Apps in Oncology: A Survey on Health Care Professionals' Attitude Toward Telemedicine, mHealth, and Oncological Apps.

Authors:  Kerstin A Kessel; Marco M E Vogel; Friederike Schmidt-Graf; Stephanie E Combs
Journal:  J Med Internet Res       Date:  2016-11-24       Impact factor: 5.428

6.  "From the technology came the idea": safe implementation and operation of a high quality teleradiology model increasing access to timely breast cancer assessment services for women in rural Australia.

Authors:  Karen Johnston; Deborah Smith; Robyn Preston; Rebecca Evans; Karen Carlisle; Janet Lengren; Helen Naess; Elizabeth Phillips; Greg Shephard; Lorraine Lydiard; Debbie Lattimore; Sarah Larkins
Journal:  BMC Health Serv Res       Date:  2020-11-30       Impact factor: 2.655

7.  Rapid Implementation of Telemedicine During the COVID-19 Pandemic: Perspectives and Preferences of Patients with Cancer.

Authors:  Shira Peleg Hasson; Barliz Waissengrin; Eliya Shachar; Marah Hodruj; Rochelle Fayngor; Mirika Brezis; Alla Nikolaevski-Berlin; Sharon Pelles; Tamar Safra; Ravit Geva; Ido Wolf
Journal:  Oncologist       Date:  2021-02-01       Impact factor: 5.837

8.  Agreement between face-to-face and tele-assessment of upper limb disability in lung cancer survivors during COVID-19 era.

Authors:  Alejandro Heredia-Ciuró; Antonio Lazo-Prados; Paula Blasco-Valls; Andrés Calvache-Mateo; Laura Lopez-Lopez; Javier Martin-Nuñez; Marie C Valenza
Journal:  J Telemed Telecare       Date:  2022-02-25       Impact factor: 6.184

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.